ArticleHealthcare (Basel, Switzerland)2026

Assessing the Early Economic Feasibility of a Curative Gene Therapy for Multiple Sclerosis Using a Risk-Adjusted Valuation Framework.

Attila Imre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.